Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

ABSTRACT:

SUBMITTER: de Vos M

PROVIDER: S-EPMC6518951 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

de Vos Margaretha M Ley Serej D SD Wiggins Kristin B KB Derendinger Brigitta B Dippenaar Anzaan A Grobbelaar Melanie M Reuter Anja A Dolby Tania T Burns Scott S Schito Marco M Engelthaler David M DM Metcalfe John J Theron Grant G van Rie Annelies A Posey James J Warren Rob R Cox Helen H

The New England journal of medicine 20190501 22

PMID: 31141643

Similar Datasets

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.

Project description: Not available

| S-EPMC6478224 | biostudies-literature

Mycobacterium tuberculosis transcriptional response to Bedaquiline

Project description:The ability of Mycobacterium tuberculosis (Mtb) to adopt heterogeneous physiological states, underlies it’s success in evading the immune system and tolerating antibiotic killing. Drug tolerant phenotypes are a major reason why the tuberculosis (TB) mortality rate is so high, with over 1.8 million deaths annually. To develop new TB therapeutics that better treat the infection (faster and more completely), a systems-level approach is needed to reveal the complexity of network-based adaptations of Mtb. Here, we report the transcriptional response of Mtb to the drug Bedaquiline. We performed transcriptomic sequencing (RNA-seq) on Mtb bacilli at 4, 24, 72 h following exposure to the drug.

2021-12-15 | GSE166546 | GEO

Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study.

Project description: Not available

| S-EPMC11838984 | biostudies-literature

Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.

Project description: Not available

| S-EPMC7350275 | biostudies-literature

Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study.

Project description: Not available

| S-EPMC12662777 | biostudies-literature

Smoking cessation interventions for pulmonary tuberculosis treatment outcomes.

Project description: Not available

| S-EPMC7386791 | biostudies-literature

Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review.

Project description: Not available

| S-EPMC8963286 | biostudies-literature

Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Project description: Not available

| S-EPMC9907500 | biostudies-literature

Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment.

Project description: Not available

| S-EPMC8923200 | biostudies-literature

Transcriptional Response of Mycobacterium tuberculosis H37Rv to Bedaquiline

Project description:Bacteria commonly adapt to stresses by altering gene expression. To understand the response of M. tuberculosis (MTB) to bedaquiline, we performed transcriptomics over a time-course on MTB bacilli exposed to the drug.

2016-05-05 | GSE72459 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data